Cognitive enhancers for the treatment of ADHD - PubMed (original) (raw)

Review

Cognitive enhancers for the treatment of ADHD

L Cinnamon Bidwell et al. Pharmacol Biochem Behav. 2011 Aug.

Abstract

Attention-deficit hyperactivity disorder (ADHD) is associated with multiple cognition-related phenotypic features in both children and adults. This review aims to clarify the role of cognition in ADHD and how prevailing treatments, which are often highly effective at reducing the clinical symptoms of the disorder, fare in modulating ADHD-related cognitive processes. First, we consider how the broad construct of cognition can be conceptualized in the context of ADHD. Second, we review the available evidence for how a range of both pharmacological and non-pharmacological interventions have fared with respect to enhancing cognition in individuals affected by this pervasive disorder. Findings from the literature suggest that the effects across a broad range of pharmacological and non-pharmacological interventions on the characteristic symptoms of ADHD can be distinguished from their effects on cognitive impairments. As such the direct clinical relevance of cognition enhancing effects of different interventions is somewhat limited. Recommendations for future research are discussed, including the identification of cognition-related endophenotypes, the refinement of the ADHD clinical phenotype, and studying the difference between acute and chronic treatment regimens.

PubMed Disclaimer

Cited by

Lifetime evolution of ADHD treatment.
Mucci F, Carpita B, Pagni G, Vecchia AD, Bjedov S, Pozza A, Marazziti D. Mucci F, et al. J Neural Transm (Vienna). 2021 Jul;128(7):1085-1098. doi: 10.1007/s00702-021-02336-w. Epub 2021 May 15. J Neural Transm (Vienna). 2021. PMID: 33993352 Review.
Chronic Cocaine Use and Parkinson's Disease: An Interpretative Model.
Carbone MG, Maremmani I. Carbone MG, et al. Int J Environ Res Public Health. 2024 Aug 21;21(8):1105. doi: 10.3390/ijerph21081105. Int J Environ Res Public Health. 2024. PMID: 39200714 Free PMC article.
Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers.
Family N, Maillet EL, Williams LTJ, Krediet E, Carhart-Harris RL, Williams TM, Nichols CD, Goble DJ, Raz S. Family N, et al. Psychopharmacology (Berl). 2020 Mar;237(3):841-853. doi: 10.1007/s00213-019-05417-7. Epub 2019 Dec 18. Psychopharmacology (Berl). 2020. PMID: 31853557 Free PMC article. Clinical Trial.
Fluphenazine-Induced Neurotoxicity with Acute Almost Transient Parkinsonism and Permanent Memory Loss: Lessons from a Case Report.
De Masi R, Orlando S, Toni V, Costa MC. De Masi R, et al. Int J Mol Sci. 2023 Feb 3;24(3):2968. doi: 10.3390/ijms24032968. Int J Mol Sci. 2023. PMID: 36769288 Free PMC article.
Neurodevelopmental disorders and gut-brain interactions: exploring the therapeutic potential of pycnogenol through microbial-metabolic-neural networks.
Chen L, Li Z, Fan Y. Chen L, et al. Front Cell Infect Microbiol. 2025 Jun 11;15:1601888. doi: 10.3389/fcimb.2025.1601888. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40568709 Free PMC article. Review.

References

1. Addy NA, Nakijama A, Levin ED. Nicotinic mechanisms of memory: effects of acute local DHbetaE and MLA infusions in the basolateral amygdala. Brain Res Cogn Brain Res. 2003;16:51–57. - PubMed
1. Advokat C. What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD) Neurosci Biobehav Rev. 2010;34:1256–1266. - PubMed
1. Akhondzadeh S, Tavakolian R, Davari-Ashtiani R, Arabgol F, Amini H. Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:841–845. - PubMed
1. Amiri S, Mohammadi MR, Mohammadi M, Nouroozinejad GH, Kahbazi M, Akhondzadeh S. Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:145–149. - PubMed
1. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999;56:1073–1086. - PubMed

Cognitive enhancers for the treatment of ADHD - PubMed (original) (raw)